UPC Universe points to strong generic drug sales momentum as key driver of its latest quarterly results CRBG Corebridge posts Q4 2025 78 percent EPS beat shares dip slightly on tepid investor sentiment BristolMyers Squibb BMY Q1 2026 Earnings Preview Consensus Estimates Historical Performance and Sector Readthrough Is Lyft LYFT stock considered stable Q4 2025 EPS Tops Views RA Brookfield outlines new strategic priorities to boost income from its global real assets portfolio Is Palantir Technologies PLTR stock forming a breakout pattern Q4 2025 EPS Tops Views ServiceNow Inc NOW Undervalued AI Play Poised for Upside Amid Sector Rotation Volatility What management guidance Maravai MRVI 014 20260427